Xtant Medical Holdings Inc (XTNT) |
|
0.8237 0.034 (4.27%)
|
10-01 08:19 |
|
Open: |
0.8489 |
Pre. Close: |
0.79 |
|
High:
|
0.8489 |
Low:
|
0.800701 |
|
Volume:
|
100,908 |
Market Cap:
|
11M |
|
|
|
|
Xtant Medical Holdings, Inc. designs, and develops orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. The company is headquartered in Belgrade Montana, Montana and currently employs 166 full-time employees. The firm operates through the development, manufacture and marketing of regenerative medical products and devices segment. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, BacFast HD, OsteoSTX, hMatrix and 3Demin products, as well as other allografts. Its products serve the needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, foot and ankle surgeries. The company also processes and distributes sports allografts, milled spinal allografts and allografts for multi-disciplinary applications. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.851 - 0.855 |
0.855 - 0.858 |
|
Low:
|
0.791 - 0.795 |
0.795 - 0.799 |
|
Close:
|
0.813 - 0.82 |
0.82 - 0.826 |
|
Technical analysis |
as of: 2020-09-30 4:48:14 PM |
|
Overall:
|
  |
| Stoxline posted a STRONG BUY today, upgraded from lower rating. Upward movement to be expected. |
| Target: |
Six months: 1.07  One year: 1.23 |
| Support: |
Support1: 0.71 Support2: 0.59 |
| Resistance: |
Resistance1: 0.92 Resistance2: 1.05 |
| Pivot: |
0.83 |
| Moving Average: |
MA(5): 0.80 MA(20): 0.83
MA(100): 1.01 MA(250): 1.27 |
| MACD: |
MACD(12,26): -0.05 Signal(9): -0.05 |
| Stochastic oscillator: |
%K(14,3): 50.51 %D(3): 45.29 |
| RSI: |
RSI(14): 44.34 |
| 52-week: |
High: 3.50 Low: 0.55 Change(%): -70.7 |
| Average Vol(K): |
3-Month: 104155 10-Days: 5099 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.XTNT has closed above bottom band by 43.1%. Bollinger Bands are 68.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to XTNT's normal range. The bands have been in this narrow range for 10 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Thu, 24 Sep 2020
Shares Of Xtant Medical Holdings, Inc. (XTNT) Recently Pulled Back, Is It Ready To Climb? - Invest Million
Mon, 24 Aug 2020
Xtant Medical Announces U.S. Commercial Launch of the Matriform® Si for Spinal Fusion Procedures - GlobeNewswire
Sat, 15 Aug 2020
Kaskela Law LLC Announces Investigation of Xtant Medical Holdings, Inc. (XTNT) and Encourages XTNT Stockholders to Contact the Firm - PRNewswire
Wed, 12 Aug 2020
Should You Buy Xtant Medical Holdings Inc (XTNT) Stock After it Has Gained 26.17% in a Week? - InvestorsObserver
Mon, 10 Aug 2020
Xtant Medical Announces Debt Restructuring NYSE:XTNT - GlobeNewswire
Mon, 03 Aug 2020
Xtant Medical Announces Second Quarter 2020 Financial Results - OrthoSpineNews
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Neutral |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Underperform |
| Return on Equity: |
Neutral |
Debt to Equity: |
Underperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: AMEX |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. (M) |
13 |
| Shares Float (M) |
2 |
|
% Held by Insiders
|
6.40 |
|
% Held by Institutions
|
89.66 |
|
Shares Short (K)
|
25 |
|
Shares Short P. Month (K)
|
13 |
Stock Financials |
|
EPS
|
-0.610 |
|
EPS Est This Year
|
-1.290 |
|
EPS Est Next Year
|
-0.450 |
|
Book Value (p.s.)
|
-3.520 |
|
Profit Margin
|
-12.62 |
|
Operating Margin
|
-5.50 |
|
Return on Assets (ttm)
|
-4.8 |
|
Return on Equity (ttm)
|
|
|
Qtrly Rev. Growth
|
-11.6 |
|
Gross Profit (p.s.)
|
3.216 |
|
Sales Per Share
|
4.745 |
|
EBITDA (p.s.)
|
-0.030 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-3 |
|
Levered Free Cash Flow (M)
|
-6 |
Stock Valuations |
|
PE Ratio
|
-1.35 |
|
PEG Ratio
|
|
|
Price to Book value
|
-0.23 |
|
Price to Sales
|
0.17 |
|
Price to Cash Flow
|
-4.05 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
